The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
Author:
Affiliation:
1. Eli Lilly and Company Indianapolis Indiana USA
2. Research Program for Clinical and Molecular Medicine Unit Diabetes and Obesity, University of Helsinki Helsinki Finland
Funder
Eli Lilly and Company
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14174
Reference47 articles.
1. Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
2. Lipids and Lipoproteins in Patients With Type 2 Diabetes
3. New insights into the pathophysiology of dyslipidemia in type 2 diabetes
4. Dyslipidemia of the metabolic syndrome
5. A VOYAGER meta‐analysis of the impact of statin therapy on low‐density lipoprotein cholesterol and triglyceride levels in patients with hypertriglyceridemia;Karlson BW;Am J Cardiol.,2016
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: An exploratory subgroup analysis of SURPASS‐AP‐Combo;Diabetes, Obesity and Metabolism;2024-02
2. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?;Pharmacological Research;2024-02
3. Treatment of type 2 diabetes;Die Diabetologie;2024-01-30
4. Polyagonists in Type 2 Diabetes Management;Current Diabetes Reports;2023-12-27
5. Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular Protection;Canadian Journal of Cardiology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3